Osaic Holdings
SMMT icon

Osaic Holdings’s Summit Therapeutics SMMT Stock Holding History

Osaic Holdings’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76.6K Sell
5,255
-143
-3% -$2.54K ﹤0.01% 5159
2026
Q1 		$102K Buy
5,398
+117
+2% +$1.89K ﹤0.01% 4669
2025
Q4 		$92.4K Sell
5,281
-212
-4% -$3.99K ﹤0.01% 4779
2025
Q3 		$123K Sell
5,493
-571
-9% -$13.8K ﹤0.01% 4615
2025
Q2 		$129K Sell
6,064
-5,979
-50% -$136K ﹤0.01% 4290
2025
Q1 		$232K Sell
12,043
-1,484
-11% -$29.8K ﹤0.01% 3507
2024
Q4 		$241K Buy
13,527
+1,488
+12% +$28.8K ﹤0.01% 3437
2024
Q3 		$264K Buy
12,039
+11,589
+2,575% +$162K ﹤0.01% 3429
2024
Q2 		$3.51K Sell
450
-11,411
-96% -$61.6K ﹤0.01% 6346
2024
Q1 		$49.1K Sell
11,861
-132,095
-92% -$525K ﹤0.01% 4765
2023
Q4 		$376K Sell
143,956
-25,622
-15% -$52.7K ﹤0.01% 3396
2023
Q3 		$317K Buy
169,578
+1,200
+0.7% +$2.29K ﹤0.01% 3641
2023
Q2 		$423K Buy
168,378
+12,809
+8% +$23.4K ﹤0.01% 3287
2023
Q1 		$272K Buy
155,569
+109,395
+237% +$298K ﹤0.01% 3618
2022
Q4 		$197K Buy
46,174
+5,800
+14% +$10.6K ﹤0.01% 3853
2022
Q3 		$48K Buy
40,374
+29,774
+281% +$33.7K ﹤0.01% 4942
2022
Q2 		$11K Buy
10,600
+1,000
+10% +$1.4K ﹤0.01% 6032
2022
Q1 		$24K Sell
9,600
-150
-2% -$378 ﹤0.01% 5584
2021
Q4 		$26K Sell
9,750
-1,330
-12% -$6.39K ﹤0.01% 5622
2021
Q3 		$56K Buy
11,080
+5,100
+85% +$36.6K ﹤0.01% 5019
2021
Q2 		$44K Buy
+5,980
New +$39.2K ﹤0.01% 5140

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Osaic Holdings's SMMT Position: Q2 2026 in Review

Osaic Holdings reduced its Summit Therapeutics (SMMT) stake by 2.6% in Q2 2026, selling an estimated $2.54K and leaving 5,255 shares worth $76.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5159.

Osaic Holdings first reported a position in SMMT in Q2 2021 and has held it in 21 quarters since. The position peaked at $423K in Q2 2023. 242 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • Osaic Holdings held 5,255 shares of Summit Therapeutics worth $76.6K as of Q2 2026.
  • Osaic Holdings sold 143 Summit Therapeutics shares in Q2 2026, an estimated $2.54K.
  • Summit Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5159 holding.
  • Osaic Holdings first reported a position in Summit Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • Osaic Holdings's Summit Therapeutics position peaked at $423K in Q2 2023.
  • 242 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.